Serum is instead prioritising state immunisation campaigns
The UN children's agency said it will have access to up to 1.1 billion doses of vaccines for around 100 countries
As of now, Covax has not disclosed the India distribution plan for the Pfizer-BioNTech vaccine
The Centre on Wednesday placed a second purchase order with the Serum Institute of India for the supply of one crore doses of Oxford-AstraZeneca COVID-19 vaccine Covishield'
Serum Institute will supply 1.1 billion doses of Covid-19 vaccines developed by AstraZeneca and Novavax to the COVAX vaccine scheme
Serum Institute of India and Bharat Biotech applauded the government's increased allocation for the healthcare sector and on providing Rs 35,000 crore towards Covid-19 vaccination in 2021-22 fiscal.
A local court has rejected an application seeking injunction against the use of 'Covishield' as brandname by the vaccine-maker Serum Institute of India
SII is already manufacturing millions of doses of Covishield vaccine in technical collaboration with Oxford University and AstraZeneca
India's Ministry of External Affairs had announced vaccine rollout for several countries from January 20
After the arrival of the vaccine doses via Dubai, these will undergo some processes for 10 to 14 days, after which these will be distributed among provinces, he said during a virtual press conference
To raise manufacturing capacity by 30% over next 2 months from present 2.4 mn doses
While mass airlifting of vaccines is yet to begin, global deal-making shows many interesting trends
The fastest Covid-19 vaccination rollouts globally, in Israel and the United Arab Emirates, are propelling their equities to the top of the world in 2021
A major fire had broken out two days ago, killing five persons
In the last few days, India has sent consignments of domestically produced coronavirus vaccines under grant assistance to Bhutan, Maldives, Nepal, Bangladesh, Myanmar, Mauritius and Seychelles
Five contractual labourers died in the fire that broke out in a five-storey building in the SII's Manjari premises in Pune on Thursday.
A Pune court hearing a suit filed by a pharmaceutical firm over the brand name 'Covishield', used by the SII for its COVID-19 vaccine, is likely to deliver its order in the case on January 30
In an interaction with beneficiaries from his constituency, PM assures both vaccines safe
A probe is on to ascertain the cause of the blaze that killed five workers at Serum Institute of India's premises here
The forensic team visited the incident site to collect samples for investigation